TICLOPIDINE: 515 Adverse Event Reports & Safety Profile
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
515
Total FAERS Reports
43 (8.3%)
Deaths Reported
324
Hospitalizations
515
As Primary/Secondary Suspect
15
Life-Threatening
3
Disabilities
Apr 26, 2000
FDA Approved
Discontinued
Status
Yes
Generic Available
FDA Application: 019979 ·
First Report: 19880201 · Latest Report: 20240116
What Are the Most Common TICLOPIDINE Side Effects?
#1 Most Reported
Anaemia
72 reports (14.0%)
#2 Most Reported
Melaena
40 reports (7.8%)
#3 Most Reported
Drug interaction
40 reports (7.8%)
All TICLOPIDINE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Anaemia | 72 | 14.0% | 8 | 54 |
| Drug interaction | 40 | 7.8% | 6 | 28 |
| Melaena | 40 | 7.8% | 4 | 27 |
| Asthenia | 28 | 5.4% | 2 | 22 |
| Cerebral haemorrhage | 28 | 5.4% | 8 | 17 |
| Drug hypersensitivity | 25 | 4.9% | 0 | 12 |
| Drug abuse | 24 | 4.7% | 0 | 21 |
| Rectal haemorrhage | 24 | 4.7% | 0 | 18 |
| Sopor | 23 | 4.5% | 3 | 16 |
| Aphasia | 20 | 3.9% | 0 | 16 |
| Hypotension | 20 | 3.9% | 4 | 11 |
| Malaise | 20 | 3.9% | 0 | 14 |
| Pyrexia | 16 | 3.1% | 0 | 12 |
| Renal impairment | 15 | 2.9% | 0 | 14 |
| Subdural haematoma | 15 | 2.9% | 6 | 10 |
| Thrombocytopenia | 15 | 2.9% | 2 | 4 |
| Diarrhoea | 14 | 2.7% | 0 | 12 |
| Vomiting | 14 | 2.7% | 0 | 7 |
| Abdominal pain upper | 13 | 2.5% | 2 | 10 |
| Dermatitis exfoliative | 13 | 2.5% | 0 | 12 |
Who Reports TICLOPIDINE Side Effects? Age & Gender Data
Gender: 47.2% female, 52.8% male. Average age: 76.1 years. Most reports from: IT. View detailed demographics →
Is TICLOPIDINE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2001 | 1 | 0 | 0 |
| 2002 | 2 | 0 | 1 |
| 2003 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 0 |
| 2007 | 6 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 5 | 0 | 5 |
| 2010 | 9 | 2 | 3 |
| 2011 | 4 | 1 | 4 |
| 2012 | 4 | 3 | 3 |
| 2013 | 22 | 5 | 13 |
| 2014 | 69 | 6 | 51 |
| 2015 | 30 | 1 | 24 |
| 2016 | 22 | 4 | 14 |
| 2017 | 47 | 1 | 30 |
| 2018 | 32 | 0 | 18 |
| 2019 | 49 | 2 | 40 |
| 2020 | 21 | 2 | 10 |
| 2021 | 10 | 4 | 1 |
| 2022 | 7 | 0 | 6 |
| 2023 | 6 | 1 | 2 |
| 2024 | 1 | 0 | 1 |
What Is TICLOPIDINE Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 145 |
| Thrombosis prophylaxis | 65 |
| Prophylaxis | 39 |
| Antiplatelet therapy | 24 |
| Atrial fibrillation | 14 |
| Anticoagulant therapy | 12 |
| Transient ischaemic attack | 11 |
| Arteriosclerosis | 9 |
| Cerebral infarction | 8 |
| Myocardial infarction | 8 |
TICLOPIDINE vs Alternatives: Which Is Safer?
TICLOPIDINE vs TIGECYCLINE
TICLOPIDINE vs TIKOSYN
TICLOPIDINE vs TILDRAKIZUMAB
TICLOPIDINE vs TILDRAKIZUMAB-ASMN
TICLOPIDINE vs TILIDINE
TICLOPIDINE vs TIMOLOL
TICLOPIDINE vs TIMOLOL\TRAVOPROST
TICLOPIDINE vs TINIDAZOLE
TICLOPIDINE vs TINZAPARIN
TICLOPIDINE vs TIOCONAZOLE
Official FDA Label for TICLOPIDINE
Official prescribing information from the FDA-approved drug label.